Market Tracker

10/23 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

115.57
Delayed Data
As of Oct 23
 +0.87 / +0.76%
Today’s Change
31.38
Today|||52-Week Range
126.16
+208.68%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close114.70
Today’s open114.66
Day’s range112.95 - 116.46
Volume809,807
Average volume (3 months)1,200,334
Market cap$10.5B
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-10.98%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book10.71

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-1.11-2.19%
SGENSeattle Genetics Inc-1.49-2.33%
TSROTESARO Inc-2.76-2.37%
JAZZJazz Pharmaceuticals...-3.89-2.70%
Data as of 4:00pm ET, 10/23/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$1.31
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts